The results from Eli Lilly's Phase 3 trial of Donanemab showed that the drug significantly slowed cogntive and functional decline for early symptomatic Alzheimer's disease patients, decreasing their risk of disease progression. Their recent press release stated that "nearly half of participants at earlier stage of disease on donanemab had no clinical progression at 1 year".
This study demonstrates the importance of an early diagnosis and brings hope to people with Alzheimer's disease.
Are you a vegan or vegetarian woman, at least 18 years old, live within 40 miles of Norwich and in good health?
The Quadram institute are conducting a 17-week study to investigate the use of hydroponically-grown, biofertified salad greens, and use of a dietary app, on iron and B12 status in vegan or vegetarian women of child-bearing age.
PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired PrecisionMed, LLC, a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.
Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.
Abzena have announced the recent appointment of Thomas Castellano as Chief Financial Office (CFO). Abzena is a leading biopharmaceutical company headquartered at Babraham Research Research Campus in Cambridge, UK. Last year, they opened a new biologics testing laboratory in San Diego, near their Biologics process development and manufacturing hub.
AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.
Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
Anglia Ruskin University (ARU) and Writtle University College are delighted to announce a proposal to merge the two institutions.
The proposed merger will secure a long-term, sustainable future for Writtle, and unlock significant opportunities for growth and development by bringing together the two institutions’ strengths across education and research.
Now in its 130th year and located on the outskirts of Chelmsford, Writtle University College is one of the UK’s leading institutions for land-based studies.
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. The programme will lay healthy foundations for future company success and equip early stage life science businesses with the skills needed when pitching to investors.